→ Hammer, F., Malzahn, U., Donhauser, J., Betz, C., Schneider, M., Grupp, C.,... Zimmermann, J. (2019). A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients. Kidney International. https://dx.doi.org/10.1016/j.kint.2018.11.025 |
→ Zeiser, R., Beelen, D.W., Bethge, W., Bornhäuser, M., Bug, G., Burchert, A.,... Müller, L.P. (2019). Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation. https://dx.doi.org/10.1016/j.bbmt.2019.01.016 |
→ Wolff, D., Hilgendorf, I., Wagner-Drouet, E., Jedlickova, Z., Ayuk, F., Zeiser, R.,... Greinix, H. (2019). Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland. Biology of Blood and Marrow Transplantation. https://dx.doi.org/10.1016/j.bbmt.2019.03.003 |
→ Fokas, E., Allgaeuer, M., Polat, B., Klautke, G., Grabenbauer, G., Fietkau, R.,... Roedel, C. (2019). Chemoradiotherapy plus induction versus consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-12 multicentre, open-label, randomised, phase 2 trial. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S40-S40). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG. |
→ Fokas, E., Allgaeuer, M., Polat, B., Klautke, G., Grabenbauer, G., Fietkau, R.,... Roedel, C. (2019). Chemo-RT plus induction or consolidation chemotherapy for rectal cancer: a randomised phase 2 trial. In RADIOTHERAPY AND ONCOLOGY (pp. S257-S258). Milan, IT: CLARE: ELSEVIER IRELAND LTD. |
→ Lüders, H., Akamatsu, N., Amina, S., Baumgartner, C., Benbadis, S., Bermeo-Ovalle, A.,... Kahane, P. (2019). Critique of the 2017 epileptic seizure and epilepsy classifications. Epilepsia. https://dx.doi.org/10.1111/epi.14699 |
→ Schöfl, C., Mayr, B., Maison, N., Beuschlein, F., Meyer, G., Badenhoop, K.,... Quinkler, M. (2019). Daily adjustment of glucocorticoids by patients with adrenal insufficiency. Clinical Endocrinology. https://dx.doi.org/10.1111/cen.14004 |
→ Laakmann, E., Witzel, I., Fasching, P., Rezai, M., Schem, C., Solbach, C.,... Loibl, S. (2019). Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto. Breast Cancer Research, 21(1). https://dx.doi.org/10.1186/s13058-019-1144-x |
→ Gulden, C., Landerer, I., Nassirian, A., Altun, F.B., & Andrae, J. (2019). Extraction and prevalence of structured data elements in free-text clinical trial eligibility criteria. In Amnon Shabo, Inge Madsen, Thomas M. Deserno, Matthias Lobe, Kristiina Hayrinen, Hans-Ulrich Prokosch, Fernando Martin-Sanchez, Klaus-Hendrik Wolf (Eds.), Proceedings of the EFMI 2019 Special Topic Conference (pp. 226-230). Amsterdam: IOS Press. |
→ Goebell, P., Hermann, E., Kube, U., Doehn, C., Marschner, N., Dietel, A.,... Bergmann, L. (2019). Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO Study. Oncology Research and Treatment, 42(1-2), 57-66. https://dx.doi.org/10.1159/000494278 |
→ Strnad, P., Buch, S., Hamesch, K., Fischer, J., Rosendahl, J., Schmelz, R.,... Trautwein, C. (2019). Heterozygous carriage of the alpha1-antitrypsin Pi∗Z variant increases the risk to develop liver cirrhosis. Gut, 68(6), 1099-1107. https://dx.doi.org/10.1136/gutjnl-2018-316228 |
→ Polifka, I., Agaimy, A., Herrmann, E., Spath, V., Trojan, L., Stoeckle, M.,... Hartmann, A. (2019). High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma. Human Pathology, 83, 212-223. https://dx.doi.org/10.1016/j.humpath.2018.08.006 |
→ Welker, M.-W., Weiler, N., Bechstein, W.O., Herrmann, E., Betz, C., Schoeffauer, M.,... Jung, O. (2019). Key role of renal biopsy in management of progressive chronic kidney disease in liver graft recipients. Journal of Nephrology, 32(1), 129-137. https://dx.doi.org/10.1007/s40620-018-0506-2 |
→ Kohmer, N., Nagel, A.M., Berger, A., Enders, M., Hamprecht, K., Korn, K.,... Rabenau, H.F. (2019). Laboratory diagnosis of congenital CMV infection in newborns: Impact of pre-analytic factors. Journal of Clinical Virology, 115, 32-36. https://dx.doi.org/10.1016/j.jcv.2019.03.017 |
→ Diefenhardt, M., Hofheinz, R.-D., Martin, D., Beissbarth, T., Arnold, D., Hartmann, A.,... Fokas, E. (2019). Leukocytosis and Neutrophilia as independent prognostic Biomarkers for clinical Outcome in the randomized Phase III CAO/ARO/AIO-04 Rectal Cancer Study. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S44-S45). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG. |
→ Ott, O.J., Micke, O., Muecke, R., Niewald, M., Roedel, F., Schaefer, U.,... Gaipl, U. (2019). Low-dose radiotherapy: Mayday, mayday. We've been hit! Strahlentherapie und Onkologie, 195(4), 285-288. https://dx.doi.org/10.1007/s00066-018-1412-1 |
→ Sembill, J.A., Kuramatsu, J.B., Hohnloser, S.H., & Huttner, H. (2019). Management von intrazerebralen Blutungen unter oraler Antikoagulation. Herz, 44(4), 315-323. https://dx.doi.org/10.1007/s00059-019-4802-y |
→ Diefenhardt, M., Hofheinz, R., Beissbarth, T., Arnold, D., Von Den Gruen, J.M., Liersch, T.,... Fokas, E. (2019). Neutrophilia as prognostic factor for outcome in the CAO/ARO/ALO-04 phase 3 rectal cancer trial. In RADIOTHERAPY AND ONCOLOGY (pp. S256-S257). Milan, IT: CLARE: ELSEVIER IRELAND LTD. |
→ Reese, I., Schaefer, C., Kleine-Tebbe, J., Ahrens, B., Bachmann, O., Ballmer-Weber, B.,... Worm, M. (2019). Nicht-zöliakie-gluten-/weizen-sensitivität (ncgs) – ein bislang nicht definiertes krankheitsbild mit fehlenden diagnosekriterien und unbekannter häufigkeit. Allergologie, 42(3), 111-117. https://dx.doi.org/10.5414/ALX02060 |
→ Reese, I., Schaefer, C., Kleine-Tebbe, J., Ahrens, B., Bachmann, O., Ballmer-Weber, B.,... Worm, M. (2019). Non-celiac gluten/wheat sensitivity (NCGS) - a currently undefined disorder without validated diagnostic criteria and of unknown prevalence. Allergologie, 42(3), 111-117. https://dx.doi.org/10.5414/ALX02060 |